• 209 Citations
  • 9 h-Index
20082019
If you made any changes in Pure these will be visible here soon.

Fingerprint Dive into the research topics where Yota Yasumizu is active. These topic labels come from the works of this person. Together they form a unique fingerprint.

  • 21 Similar Profiles
docetaxel Medicine & Life Sciences
Castration Medicine & Life Sciences
Renal Cell Carcinoma Medicine & Life Sciences
Prostatic Neoplasms Medicine & Life Sciences
Prostatectomy Medicine & Life Sciences
Triple Negative Breast Neoplasms Medicine & Life Sciences
Lymphocele Medicine & Life Sciences
Therapeutics Medicine & Life Sciences

Network Recent external collaboration on country level. Dive into details by clicking on the dots.

Research Output 2008 2019

  • 209 Citations
  • 9 h-Index
  • 28 Article
  • 1 Comment/debate

Correction: MUC1-C represses the RASSF1A tumor suppressor in human carcinoma cells (Oncogene, (2019), 38, 47, (7266-7277), 10.1038/s41388-019-0940-1)

Rajabi, H., Hata, T., Li, W., Long, M. D., Hu, Q., Liu, S., Raina, D., Kui, L., Yasumizu, Y., Hong, D., Samur, M. & Kufe, D., 2019 Nov 21, In : Oncogene. 38, 47, 1 p.

Research output: Contribution to journalComment/debate

Open Access
Oncogenes
Carcinoma
Neoplasms
2 Citations (Scopus)

Impact of inflammatory marker levels one month after the first-line targeted therapy initiation on progression-free survival prediction in patients with metastatic clear cell renal cell carcinoma

Ito, K., Masunaga, A., Tanaka, N., Mizuno, R., Shirotake, S., Yasumizu, Y., Ito, Y., Miyazaki, Y., Hagiwara, M., Kanao, K., Mikami, S., Momma, T., Masuda, T., Nakagawa, K., Oyama, M., Asano, T. & Oya, M., 2019 Jan 1, In : Japanese Journal of Clinical Oncology. 49, 1, p. 69-76 8 p.

Research output: Contribution to journalArticle

Disease-Free Survival
L-Lactate Dehydrogenase
Neutrophils
Lymphocytes
Therapeutics

MUC1-C activates the NuRD complex to drive dedifferentiation of triple-negative breast cancer cells

Hata, T., Rajabi, H., Takahashi, H., Yasumizu, Y., Li, W., Jin, C., Long, M. D., Hu, Q., Liu, S., Fushimi, A., Yamashita, N., Kui, L., Hong, D., Yamamoto, M., Miyo, M., Hiraki, M., Maeda, T., Suzuki, Y., Samur, M. K. & Kufe, D., 2019 Jan 1, In : Cancer Research. 79, 22, p. 5711-5722 12 p.

Research output: Contribution to journalArticle

Mi-2 Nucleosome Remodeling and Deacetylase Complex
Triple Negative Breast Neoplasms
Mucin-1
Chromatin Assembly and Disassembly
Protein Subunits

MUC1-C integrates chromatin remodeling and PARP1 activity in the DNA damage response of triple-negative breast cancer cells

Yamamoto, M., Jin, C., Hata, T., Yasumizu, Y., Zhang, Y., Hong, D., Maeda, T., Miyo, M., Hiraki, M., Suzuki, Y., Hinohara, K., Rajabi, H. & Kufe, D., 2019 Apr 15, In : Cancer Research. 79, 8, p. 2031-2041 11 p.

Research output: Contribution to journalArticle

Triple Negative Breast Neoplasms
Chromatin Assembly and Disassembly
DNA Damage
Polycomb-Group Proteins
Double-Stranded DNA Breaks
1 Citation (Scopus)

Targeting MUC1-C inhibits TWIst1 signaling in triple-negative breast cancer

Hata, T., Rajabi, H., Yamamoto, M., Jin, C., Ahmad, R., Zhang, Y., Kui, L., Li, W., Yasumizu, Y., Hong, D., Miyo, M., Hiraki, M., Maeda, T., Suzuki, Y., Takahashi, H., Samur, M. & Kufe, D., 2019 Jan 1, In : Molecular cancer therapeutics. 18, 10, p. 1744-1754 11 p.

Research output: Contribution to journalArticle

Triple Negative Breast Neoplasms
Paclitaxel
Twist-Related Protein 1
Protein C
Drug Resistance